organic compounds
1,3-Bis[(3-chloropyrazin-2-yl)oxy]benzene
aCentre of Advanced Study in Crystallography and Biophysics, University of Madras, Guindy Campus, Chennai 600 025, India, and bDepartment of Organic Chemistry, University of Madras, Guindy Campus, Chennai 600 025, India
*Correspondence e-mail: shirai2011@gmail.com
The 14H8Cl2N4O2, contains one half-molecule, the complete molecule being generated by the operation of a twofold rotation axis. The Cl atom deviates significantly from the plane of the pyrazine ring [0.0215 (4) Å]. The central benzene ring makes a dihedral angle of 72.82 (7)° with the plane of the pyrazine ring.
of the title compound, CRelated literature
For applications of the pyrazine ring system in drug development, see: Du et al. (2009); Dubinina et al. (2006); Ellsworth et al. (2007); Mukaiyama et al. (2007). For background to the fluorescence properties of compounds related to the title compound, see: Kawai et al. (2001); Abdullah (2005). For a related structure, see: Nasir et al. (2010).
Experimental
Crystal data
|
Data collection: APEX2 (Bruker, 2008); cell SAINT (Bruker, 2008); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: ORTEP-3 for Windows (Farrugia, 2012) and Mercury (Macrae et al., 2008); software used to prepare material for publication: SHELXL97and PLATON (Spek, 2009).
Supporting information
https://doi.org/10.1107/S160053681301129X/kp2450sup1.cif
contains datablocks global, I. DOI:Structure factors: contains datablock I. DOI: https://doi.org/10.1107/S160053681301129X/kp2450Isup2.hkl
Supporting information file. DOI: https://doi.org/10.1107/S160053681301129X/kp2450Isup3.cml
To a stirred solution of Cs2CO3/K2CO3 (22 mmol) in CH3CN (50 mL), resorcinol (10 mmol) was added and stirred for 5 min. 2,3-dichloropyrazine (20 mmol) in CH3CN (100 mL) was added dropwise to the above reaction mixture and allowed for stirring at refluxing condition for 12 h. After the reaction was complete, the reaction mixture was allowed to attain room temperature and then evaporated to dryness. The residue obtained was extracted with CH2Cl2 (3 x 100 mL), washed with water (3 x 100 mL), brine and then dried over Na2SO4. Evaporation of the organic layer gave a residue, which on purification using
with hexane/CHCl3 (1:1) as an gave the corresponding compound. Single crystals suitable for X-ray diffraction were obtained by slow evaporation of a solution of the title compound in hexane at room temperature.The hydrogen atoms were placed in calculated positions with C—H = 0.93 Å, refined in the riding model with fixed isotropic displacement parameters:Uiso(H) = 1.2Ueq(C).
The pyrazine ring system is a useful structural element in medicinal chemistry and has found broad applications in drug development which can be used as antiproliferative agent (Dubinina et al., 2006), potent CXCR3 antagonists (Du et al., 2009), CB1 antagonists (Ellsworth et al., 2007), and c-Src inhibitory (Mukaiyama et al., 2007). On-going structural studies of heterocyclic N-containing derivatives (Nasir et al., 2010) are motivated by an investigation of their fluorescence properties (Kawai et al., 2001; Abdullah, 2005). In view of different applications of this class of compounds, we have undertaken the single
determination of the title compound.The title compound C14 H8 Cl2 N4 O2, contains a half of the molecule in an
the complete molecule is generated by two the fold rotation axis along the direction [0 1 0] with the symmetry code: -x, y, -z+1/2. X-ray analysis confirms the molecular structure and atom connectivity of the compound (Fig. 1). The deviation of the atom Cl1 from the pyrazine ring (C1/N1/C2/C3/N2/C4) is -0.0215 (4) Å.The central phenyl ring (C5/C6/C7/C8/C5i/C7i) forms the dihedral angle of 72.82 (7) ° with the pyrazine ring (C1/N1/C2/C3/N2/C4). The dihedral angle between the pyrazine rings (C1/N1/C2/C3/N2/C4) and (C1i/N1i/C2i/C3i/N2i/C4i) is 68.38 (3) ° (Macrae et al., 2008). The crystal packing is via van der Waals interactions, only.
For applications of the pyrazine ring system in drug development, see: Du et al. (2009); Dubinina et al. (2006); Ellsworth et al. (2007); Mukaiyama et al. (2007). For background to the fluorescence properties of compounds related to the title compound, see: Kawai et al. (2001); Abdullah (2005). For a related structure, see: Nasir et al. (2010).
Data collection: APEX2 (Bruker, 2008); cell
SAINT (Bruker, 2008); data reduction: SAINT (Bruker, 2008); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: ORTEP-3 for Windows (Farrugia, 2012) and Mercury (Macrae, et al.,2008); software used to prepare material for publication: SHELXL97 (Sheldrick, 2008) and PLATON (Spek, 2009).C14H8Cl2N4O2 | F(000) = 680 |
Mr = 335.14 | Dx = 1.560 Mg m−3 |
Monoclinic, C2/c | Mo Kα radiation, λ = 0.71073 Å |
Hall symbol: -C 2yc | Cell parameters from 1781 reflections |
a = 9.9618 (3) Å | θ = 2.9–28.4° |
b = 10.2196 (4) Å | µ = 0.47 mm−1 |
c = 14.6010 (6) Å | T = 293 K |
β = 106.231 (2)° | Block, colourless |
V = 1427.22 (9) Å3 | 0.30 × 0.25 × 0.20 mm |
Z = 4 |
Bruker SMART APEXII area-detector diffractometer | 1781 independent reflections |
Radiation source: fine-focus sealed tube | 1552 reflections with I > 2σ(I) |
Graphite monochromator | Rint = 0.026 |
ω and φ scans | θmax = 28.4°, θmin = 2.9° |
Absorption correction: multi-scan (SADABS; Bruker, 2008) | h = −13→13 |
Tmin = 0.873, Tmax = 0.912 | k = −13→12 |
6736 measured reflections | l = −19→14 |
Refinement on F2 | Primary atom site location: structure-invariant direct methods |
Least-squares matrix: full | Secondary atom site location: difference Fourier map |
R[F2 > 2σ(F2)] = 0.036 | Hydrogen site location: inferred from neighbouring sites |
wR(F2) = 0.113 | H-atom parameters constrained |
S = 1.00 | w = 1/[σ2(Fo2) + (0.0685P)2 + 0.5533P] where P = (Fo2 + 2Fc2)/3 |
1781 reflections | (Δ/σ)max < 0.001 |
101 parameters | Δρmax = 0.25 e Å−3 |
0 restraints | Δρmin = −0.31 e Å−3 |
C14H8Cl2N4O2 | V = 1427.22 (9) Å3 |
Mr = 335.14 | Z = 4 |
Monoclinic, C2/c | Mo Kα radiation |
a = 9.9618 (3) Å | µ = 0.47 mm−1 |
b = 10.2196 (4) Å | T = 293 K |
c = 14.6010 (6) Å | 0.30 × 0.25 × 0.20 mm |
β = 106.231 (2)° |
Bruker SMART APEXII area-detector diffractometer | 1781 independent reflections |
Absorption correction: multi-scan (SADABS; Bruker, 2008) | 1552 reflections with I > 2σ(I) |
Tmin = 0.873, Tmax = 0.912 | Rint = 0.026 |
6736 measured reflections |
R[F2 > 2σ(F2)] = 0.036 | 0 restraints |
wR(F2) = 0.113 | H-atom parameters constrained |
S = 1.00 | Δρmax = 0.25 e Å−3 |
1781 reflections | Δρmin = −0.31 e Å−3 |
101 parameters |
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes. |
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > 2sigma(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger. |
x | y | z | Uiso*/Ueq | ||
C1 | 0.10770 (15) | 0.37514 (13) | −0.02670 (10) | 0.0461 (3) | |
C2 | −0.07466 (18) | 0.3213 (2) | −0.15100 (11) | 0.0644 (4) | |
H2 | −0.1203 | 0.3246 | −0.2159 | 0.077* | |
C3 | −0.13428 (17) | 0.25363 (19) | −0.09216 (11) | 0.0618 (4) | |
H3 | −0.2196 | 0.2121 | −0.1178 | 0.074* | |
C4 | 0.04654 (14) | 0.30517 (13) | 0.03426 (9) | 0.0417 (3) | |
C5 | 0.05477 (14) | 0.23121 (15) | 0.18814 (9) | 0.0454 (3) | |
C6 | 0.0000 | 0.3013 (2) | 0.2500 | 0.0436 (4) | |
H6 | 0.0000 | 0.3923 | 0.2500 | 0.052* | |
C7 | 0.05777 (19) | 0.09686 (17) | 0.18801 (10) | 0.0597 (4) | |
H7 | 0.0979 | 0.0516 | 0.1470 | 0.072* | |
C8 | 0.0000 | 0.0305 (2) | 0.2500 | 0.0694 (7) | |
H8 | 0.0000 | −0.0605 | 0.2500 | 0.083* | |
N1 | 0.04795 (16) | 0.38337 (13) | −0.11809 (9) | 0.0580 (3) | |
N2 | −0.07257 (13) | 0.24545 (13) | 0.00221 (8) | 0.0515 (3) | |
O1 | 0.11655 (11) | 0.30189 (12) | 0.12853 (7) | 0.0537 (3) | |
Cl1 | 0.26460 (5) | 0.45456 (4) | 0.01959 (4) | 0.06883 (19) |
U11 | U22 | U33 | U12 | U13 | U23 | |
C1 | 0.0581 (7) | 0.0383 (6) | 0.0511 (8) | 0.0030 (5) | 0.0308 (6) | −0.0006 (5) |
C2 | 0.0681 (10) | 0.0875 (12) | 0.0390 (7) | 0.0107 (9) | 0.0175 (7) | 0.0107 (7) |
C3 | 0.0527 (8) | 0.0885 (12) | 0.0432 (8) | −0.0002 (8) | 0.0121 (6) | 0.0067 (7) |
C4 | 0.0491 (6) | 0.0447 (7) | 0.0363 (6) | 0.0042 (5) | 0.0201 (5) | 0.0004 (5) |
C5 | 0.0493 (7) | 0.0565 (8) | 0.0298 (6) | −0.0035 (5) | 0.0104 (5) | 0.0000 (5) |
C6 | 0.0461 (9) | 0.0492 (10) | 0.0340 (8) | 0.000 | 0.0085 (7) | 0.000 |
C7 | 0.0861 (11) | 0.0587 (9) | 0.0385 (7) | 0.0055 (8) | 0.0240 (7) | −0.0053 (6) |
C8 | 0.119 (2) | 0.0472 (12) | 0.0468 (12) | 0.000 | 0.0308 (13) | 0.000 |
N1 | 0.0756 (8) | 0.0596 (8) | 0.0484 (7) | 0.0084 (6) | 0.0332 (6) | 0.0117 (6) |
N2 | 0.0489 (6) | 0.0689 (8) | 0.0387 (6) | −0.0036 (5) | 0.0157 (5) | 0.0063 (5) |
O1 | 0.0553 (6) | 0.0703 (7) | 0.0374 (5) | −0.0130 (5) | 0.0162 (4) | −0.0022 (4) |
Cl1 | 0.0778 (3) | 0.0608 (3) | 0.0815 (4) | −0.02286 (19) | 0.0447 (2) | −0.01437 (19) |
C1—N1 | 1.303 (2) | C5—C7 | 1.373 (2) |
C1—C4 | 1.4064 (18) | C5—C6 | 1.3789 (17) |
C1—Cl1 | 1.7229 (15) | C5—O1 | 1.3991 (17) |
C2—N1 | 1.340 (2) | C6—C5i | 1.3789 (17) |
C2—C3 | 1.362 (2) | C6—H6 | 0.9300 |
C2—H2 | 0.9300 | C7—C8 | 1.379 (2) |
C3—N2 | 1.345 (2) | C7—H7 | 0.9300 |
C3—H3 | 0.9300 | C8—C7i | 1.379 (2) |
C4—N2 | 1.2996 (18) | C8—H8 | 0.9300 |
C4—O1 | 1.3584 (16) | ||
N1—C1—C4 | 121.76 (14) | C6—C5—O1 | 117.57 (14) |
N1—C1—Cl1 | 118.42 (11) | C5—C6—C5i | 117.45 (19) |
C4—C1—Cl1 | 119.81 (11) | C5—C6—H6 | 121.3 |
N1—C2—C3 | 121.90 (14) | C5i—C6—H6 | 121.3 |
N1—C2—H2 | 119.0 | C5—C7—C8 | 118.51 (15) |
C3—C2—H2 | 119.0 | C5—C7—H7 | 120.7 |
N2—C3—C2 | 121.51 (15) | C8—C7—H7 | 120.7 |
N2—C3—H3 | 119.2 | C7i—C8—C7 | 121.1 (2) |
C2—C3—H3 | 119.2 | C7i—C8—H8 | 119.4 |
N2—C4—O1 | 120.78 (11) | C7—C8—H8 | 119.4 |
N2—C4—C1 | 121.62 (12) | C1—N1—C2 | 116.50 (13) |
O1—C4—C1 | 117.60 (12) | C4—N2—C3 | 116.71 (13) |
C7—C5—C6 | 122.18 (14) | C4—O1—C5 | 116.90 (10) |
C7—C5—O1 | 120.12 (13) | ||
N1—C2—C3—N2 | −0.1 (3) | C4—C1—N1—C2 | −0.2 (2) |
N1—C1—C4—N2 | 0.0 (2) | Cl1—C1—N1—C2 | −179.30 (12) |
Cl1—C1—C4—N2 | 179.08 (11) | C3—C2—N1—C1 | 0.3 (3) |
N1—C1—C4—O1 | 179.94 (13) | O1—C4—N2—C3 | −179.81 (14) |
Cl1—C1—C4—O1 | −0.95 (17) | C1—C4—N2—C3 | 0.2 (2) |
C7—C5—C6—C5i | −1.04 (11) | C2—C3—N2—C4 | −0.1 (3) |
O1—C5—C6—C5i | −176.94 (13) | N2—C4—O1—C5 | 0.4 (2) |
C6—C5—C7—C8 | 2.0 (2) | C1—C4—O1—C5 | −179.61 (12) |
O1—C5—C7—C8 | 177.84 (11) | C7—C5—O1—C4 | 75.09 (18) |
C5—C7—C8—C7i | −0.99 (11) | C6—C5—O1—C4 | −108.92 (13) |
Symmetry code: (i) −x, y, −z+1/2. |
Experimental details
Crystal data | |
Chemical formula | C14H8Cl2N4O2 |
Mr | 335.14 |
Crystal system, space group | Monoclinic, C2/c |
Temperature (K) | 293 |
a, b, c (Å) | 9.9618 (3), 10.2196 (4), 14.6010 (6) |
β (°) | 106.231 (2) |
V (Å3) | 1427.22 (9) |
Z | 4 |
Radiation type | Mo Kα |
µ (mm−1) | 0.47 |
Crystal size (mm) | 0.30 × 0.25 × 0.20 |
Data collection | |
Diffractometer | Bruker SMART APEXII area-detector |
Absorption correction | Multi-scan (SADABS; Bruker, 2008) |
Tmin, Tmax | 0.873, 0.912 |
No. of measured, independent and observed [I > 2σ(I)] reflections | 6736, 1781, 1552 |
Rint | 0.026 |
(sin θ/λ)max (Å−1) | 0.668 |
Refinement | |
R[F2 > 2σ(F2)], wR(F2), S | 0.036, 0.113, 1.00 |
No. of reflections | 1781 |
No. of parameters | 101 |
H-atom treatment | H-atom parameters constrained |
Δρmax, Δρmin (e Å−3) | 0.25, −0.31 |
Computer programs: APEX2 (Bruker, 2008), SAINT (Bruker, 2008), SHELXS97 (Sheldrick, 2008), ORTEP-3 for Windows (Farrugia, 2012) and Mercury (Macrae, et al., 2008), SHELXL97 (Sheldrick, 2008) and PLATON (Spek, 2009).
Acknowledgements
The authors thank the TBI X-ray facility, CAS in Crystallography and Biophysics, University of Madras, India, for the data collection. TS and DV thank the UGC (SAP–CAS) for the departmental facilties. TS also thanks the DST Inspire program for financial assistance.
References
Abdullah, Z. (2005). Intl J. Chem. Sci. 3 , 9–15. CAS Google Scholar
Bruker (2008). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA. Google Scholar
Du, X. H., Gustin, D. J., Chen, X. Q., Duquette, J., McGee, L. R., Wang, Z. L., Ebsworth, K., Henne, K., Lemon, B., Ma, J., Miao, S. C., Sabalan, E., Sullivan, T. J., Tonn, G., Collins, T. L. & Medina, J. C. (2009). Bioorg. Med. Chem. Lett. 19, 5200–5204. Web of Science CrossRef PubMed CAS Google Scholar
Dubinina, G. G., Platonov, M. O., Golovach, S. M., Borysko, P. O., Tolmachov, A. O. & Volovenko, Y. M. (2006). Eur. J. Med. Chem. 41, 727–737. Web of Science CrossRef PubMed CAS Google Scholar
Ellsworth, B. A., Wang, Y., Zhu, Y. H., Pendri, A., Gerritz, S. W., Sun, C. Q., Carlson, K. E., Kang, L. Y., Baska, R. A., Yang, Y. F., Huang, Q., Burford, N. T., Cullen, M. J., Johnghar, S., Behnia, K., Pelleymounter, M. A., Washburn, W. N. & Ewing, W. R. (2007). Bioorg. Med. Chem. Lett. 17, 3978–3982. Web of Science CrossRef PubMed CAS Google Scholar
Farrugia, L. J. (2012). J. Appl. Cryst. 45, 849–854. Web of Science CrossRef CAS IUCr Journals Google Scholar
Kawai, M., Lee, M. J., Evans, K. O. & Norlund, T. (2001). J. Fluoresc. 11, 23–32. Web of Science CrossRef CAS Google Scholar
Macrae, C. F., Bruno, I. J., Chisholm, J. A., Edgington, P. R., McCabe, P., Pidcock, E., Rodriguez-Monge, L., Taylor, R., van de Streek, J. & Wood, P. A. (2008). J. Appl. Cryst. 41, 466–470. Web of Science CSD CrossRef CAS IUCr Journals Google Scholar
Mukaiyama, H., Nishimura, T., Kobayashi, S., Ozawa, T., Kamada, N., Komatsu, Y., Kikuchi, S., Oonota, H. & Kusama, H. (2007). Bioorg. Med. Chem. Lett. 15, 868–885. CrossRef CAS Google Scholar
Nasir, S. B., Abdullah, Z., Fairuz, Z. A., Ng, S. W. & Tiekink, E. R. T. (2010). Acta Cryst. E66, o2187. Web of Science CSD CrossRef IUCr Journals Google Scholar
Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. Web of Science CrossRef CAS IUCr Journals Google Scholar
Spek, A. L. (2009). Acta Cryst. D65, 148–155. Web of Science CrossRef CAS IUCr Journals Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
The pyrazine ring system is a useful structural element in medicinal chemistry and has found broad applications in drug development which can be used as antiproliferative agent (Dubinina et al., 2006), potent CXCR3 antagonists (Du et al., 2009), CB1 antagonists (Ellsworth et al., 2007), and c-Src inhibitory (Mukaiyama et al., 2007). On-going structural studies of heterocyclic N-containing derivatives (Nasir et al., 2010) are motivated by an investigation of their fluorescence properties (Kawai et al., 2001; Abdullah, 2005). In view of different applications of this class of compounds, we have undertaken the single crystal structure determination of the title compound.
The title compound C14 H8 Cl2 N4 O2, contains a half of the molecule in an asymmetric unit; the complete molecule is generated by two the fold rotation axis along the direction [0 1 0] with the symmetry code: -x, y, -z+1/2. X-ray analysis confirms the molecular structure and atom connectivity of the compound (Fig. 1). The deviation of the atom Cl1 from the pyrazine ring (C1/N1/C2/C3/N2/C4) is -0.0215 (4) Å.
The central phenyl ring (C5/C6/C7/C8/C5i/C7i) forms the dihedral angle of 72.82 (7) ° with the pyrazine ring (C1/N1/C2/C3/N2/C4). The dihedral angle between the pyrazine rings (C1/N1/C2/C3/N2/C4) and (C1i/N1i/C2i/C3i/N2i/C4i) is 68.38 (3) ° (Macrae et al., 2008). The crystal packing is via van der Waals interactions, only.